Answers are grounded in this paper and cite their sources.
Introduction: Selective laser trabeculoplasty (SLT) is used successfully for management of early to advanced glaucoma and ocular hypertension (OHT). Primary open-angle glaucoma (OAG), pseudoexfoliation glaucoma (PXFG), pigmentary glaucoma, normal-tension glaucoma, primary angle-closure glaucoma, steroid-induced glaucoma, silicone oil-induced glaucoma, and high intraocular pressure after canaloplasty and trabeculectomy are the main indications.Areas covered: A review of the literature was performed to highlight recent advances in terms of suggested mechanisms, indications, efficacy, prognostic factors, surgical technique, postoperative care, complications, repeatability, cost-effectiveness, and quality of life (QoL) implications of SLT in glaucoma patients.Expert commentary: SLT is a safe, cost-effective, and repeatable procedure. It increases QoL, but it has not received wide application it deserves in glaucoma management. SLT may be a first-line treatment option in mild-to-moderate glaucoma. It may also be an adjuvant treatment in OHT and in all subtypes of glaucoma. SLT use may gain popularity in all types of OAGs, closed-angle glaucomas and OHT in the future.
No takes yet. Share an insight, caveat, or question.
Örnek et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: